Changes in pathologic outcomes and operative trends with robot-assisted laparoscopic radical prostatectomy

Indian Journal of Urology

Volumn 30, Issue 4, 2014, Pages 378-382

  Bernie, Aaron ^a   Ramasamy, Ranjith ^a   Ali, Adnan ^a   Tewari, Ashutosh ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Prostate cancer; robotics; stage migration

Indexed keywords

ARTICLE; CANCER SURGERY; CONTROLLED STUDY; GLEASON SCORE; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; ROBOTICS; TUMOR BIOPSY;

EID: 84908395946     PISSN: 09701591     EISSN: 19983824     Source Type: Journal    
DOI: 10.4103/0970-1591.142054     Document Type: Article

References (18)

1. Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, Wegelin J, et al. Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer Causes Control 2008;19:175-81.
2. Farkas A, Schneider D, Perrotti M, Cummings KB, Ward WS. National trends in the epidemiology of prostate cancer, 1973 to 1994: Evidence for the effectiveness of prostate-specific antigen screening. Urology 1998;52:444-8.
3. Mettlin CJ, Murphy GP. Why is the prostate cancer death rate declining in the United States? Cancer 1998;82:249-51.
4. Galper SL, Chen MH, Catalona WJ, Roehl KA, Richie JP, DAmico AV. Evidence to support a continued stage migration and decrease in prostate cancer specific mortality. J Urol 2006;175:907-12.
5. Moore AL, Dimitropoulou P, Lane A, Powell PH, Greenberg DC, Brown CH, et al. Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer. BJU Int 2009;104:1592-8.
6. Berger AP, Spranger R, Kofler K, Steiner H, Bartsch G, Horninger W. Early detection of prostate cancer with low PSA cut-off values leads to significant stage migration in radical prostatectomy specimens. Prostate 2003;57:93-8.
7. Silberstein JL, Vickers AJ, Power NE, Fine SW, Scardino PT, Eastham JA, et al. Reverse stage shift at a tertiary care center: Escalating risk in men undergoing radical prostatectomy. Cancer 2011;117:4855-60.
8. Budaüs L, Spethmann J, Isbarn H, Schmitges J, Beesch L, Haese A, et al. Inverse stage migration in patients undergoing radical prostatectomy: Results of 8916 European patients treated within the last decade. BJU Int 2011;108:1256-61.
9. Gallina A, Chun FK, Suardi N, Eastham JA, Perrotte P, Graefen M, et al. Comparison of stage migration patterns between Europe and the USA: An analysis of 11 350 men treated with radical prostatectomy for prostate cancer. BJU Int 2008;101:1513-8.
10. McGregor M, Hanley JA, Boivin JF, McLean RG. Screening for prostate cancer: Estimating the magnitude of overdetection. CMAJ 1998;159:1368-72.
11. Draisma G, Boer R, Otto SJ, van der Cruijsen IW, Damhuis RA, Schröder FH, et al. Lead times and overdetection due to prostate-specific antigen screening: Estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 2003;95:868-78.
12. Mohler J, Bahnson RR, Boston B, Busby JE, DAmico A, Eastham JA, et al. NCCN clinical practice guidelines in oncology: Prostate cancer. J Natl Compr Canc Netw 2010;8:162-200.
13. Derweesh IH, Kupelian PA, Zippe C, Levin HS, Brainard J, Magi-Galluzzi C, et al. Continuing trends in pathological stage migration in radical prostatectomy specimens. Urol Oncol 2004;22:300-6.
14. Mettlin C, Murphy GP, Babaian RJ, Chesley A, Kane RA, Littrup PJ, et al. The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer 1996;77:150-9.
15. Barbash GI, Glied SA. New technology and health care costs: The case of robot-assisted surgery. N Engl J Med 2010;363:701-4.
16. Epstein JI, Partin AW, Sauvageot J, Walsh PC. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 1996;20:286-92.
17. Stamey TA, Donaldson AN, Yemoto CE, McNeal JE, Sözen S, Gill H. Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: Epidemiologic significance of annual changes. J Urol 1998;160:2412-7.
18. Jhaveri FM, Klein EA, Kupelian PA, Zippe C, Levin HS. Declining rates of extracapsular extension after radical prostatectomy: Evidence for continued stage migration. J Clin Oncol 1999;17:3167-72.